Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase III Trial of Statins on Tumour Biology in Non-Small Cell Lung Cancer
2007-000903-14Phase 3Terminated
- Sponsor
- Imperial College London
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of pravastatin and lovastatin in non-small cell lung cancer (NSCLC) (3 arms), sponsored by Imperial College London. Primary endpoint: Change in tumour cell proliferation (Ki-67 expression). Started Jun 2007; status: terminated.
02
Drugs
pravastatinlovastatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-000903-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000903-14.